Principal Investigator
Enrollment Status
Clinical Trial ID
Clinical Trial Summary
The goal of this project is to use genomic profiling, candidate genes and proteins to develop
guided surgical debridement to improve healing in chronic non-healing venous leg ulcers
(VLUs) and to test the efficacy of this approach.
Phase
N/A
Funding Agency/Sponsor
Other
Disease
Skin Lesions
Enrollment Eligibility
Inclusion Criteria:
1. >18 years of age
2. Conformation of venous disease by non-invasive venous studies with either
Doppler-confirmed venous reflux, or having ≥ 2 clinical characteristics of venous
insufficiency (varicose veins, lipodermatosclersosis, venous dermatitis, atrophie
blanche, edema)
3. have a venous ulcer between the knee and ankle, at or above the malleolus
4. wound size would be greater than or equal to 5cm2 in area without exposed tendon,
muscle or bone
5. wound duration of at least 6 months
6. VLU containing yellow/white slough with or without fibrous/scar tissue and/or
non-viable tissue
7. ability of subject to tolerate limb compression bandage
Exclusion Criteria:
1. history of diabetes mellitus and a HbA1c > 12% (obtained within past 6 months)
2. Ankle brachial index(ABI) less than 0.80
3. any active cancer other than a nonmelanoma skin cancer; any previous cancer must be in
remission for at least 5 years
4. suspicion of malignancy within VLU
5. life expectancy <6 months
6. history of kidney disease and creatinine greater than 2.0 (obtained within past 6
months)
7. history of liver disease and liver function test (ALT, AST, ALK PHOS, and bilirubin)
>2x upper limit of normal (obtained within past 6 months)
8. requirement for long-term systemic corticosteroids or immunosuppressive therapy, or
history of corticosteroid or immunosuppressive use in the 4 weeks prior to study entry
9. history of immunodeficiency
10. ulcers due to none venous etiology and leg ulcers associated with mixed etiology
11. Untreated osteomyelitis
12. Hepatitis
13. acute deep venous thrombosis
14. allergy to lidocaine and/or epinephrine
15. Subject's inability to successfully tolerate compression therapy that is changed
weekly
16. Skin ulcer previously treated within the last 4 weeks with biologic therapies (e.g.
cell therapy or growth factors)
17. if currently incarcerated
18. known pregnancy